Camurus appoints VP Corporate Development & General Counsel
Lund, Sweden – 31 March 2017 — Camurus (NASDAQ STO: CAMX) today announces the appointment of Urban Paulsson to the position of Vice President Corporate Development and General Counsel and member of the Executive Management Team. He has broad experience from the pharmaceutical industry, where he during twenty plus years has worked as legal counsel focusing on licensing and transactions. Urban Paulsson will assume his position with Camurus in May 2017.
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our proprietary FluidCrystal® drug delivery technologies with the purpose to deliver improved quality of life, treatment outcomes and resource utilization. The company’s share is listed on Nasdaq Stockholm under the ticker “CAMX”. For more information, visit www.camurus.com.
For more information:
Fredrik Tiberg, CEO and Head of Research
Tel. +46 (0)46 286 46 92
The information was submitted for publication at 01.00 PM CET on 31 March 2017.